Literature DB >> 21675867

Nonmydriatic retinal image review at time of endocrinology visit results in short-term HbA1c reduction in poorly controlled patients with diabetic retinopathy.

Haytham Salti1, Jerry D Cavallerano, Nisreen Salti, Dalida Jaafar Jawhari, Sandra Haddad, Jennifer K Sun, Ibrahim Salti, Lloyd Paul Aiello.   

Abstract

OBJECTIVES: The objective of this study was to evaluate the effect of discussing retinal findings following nonmydriatic retinal imaging during an endocrinology visit on subsequent HbA1c in poorly controlled diabetic patients with diabetic retinopathy (DR).
MATERIALS AND METHODS: During a visit to an endocrinologist, patients with DR and documented HbA1c ≥ 8.0% within the preceding month were assigned to either addition of nonmydriatic imaging and discussion of retinal findings or standard endocrinology evaluation alone. Ophthalmology care was otherwise the same in both groups. Changes in HbA1c were evaluated 3 months later.
RESULTS: One hundred thirteen (94%) of the original 120 subjects completed the study. The mean HbA1c change in the retinal imaging group was a decline of 1.35%, whereas the control group had a 0.26% increase. Controlling for gender, age, duration of diabetes, presence of hypertension, and use of insulin, the difference between groups was significant (p<0.0003).
CONCLUSIONS: Nonmydriatic imaging and discussion of retinal findings during an endocrinologist visit may contribute, at least in the short term, to improved glycemic control in patients with DR and elevated HbA1c.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21675867     DOI: 10.1089/tmj.2010.0180

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  4 in total

1.  Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.

Authors:  Lloyd Paul Aiello; Allison R Ayala; Andrew N Antoszyk; Bambi Arnold-Bush; Carl Baker; Neil M Bressler; Michael J Elman; Adam R Glassman; Lee M Jampol; Michele Melia; Jared Nielsen; Howard A Wolpert
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

2.  Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs.

Authors:  Kevin Tozer; Maria A Woodward; Paula A Newman-Casey
Journal:  J Endocrinol Diabetes       Date:  2015-11-11

3.  Risk factors of retinopathy in type 2 diabetes mellitus at a tertiary care hospital, Bahawalpur Pakistan.

Authors:  Sadiq Hussain; Muhammad Rashad Qamar; Muhammad Arshad Iqbal; Ameer Ahmad; Ehsan Ullah
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

4.  A 15 month experience with a primary care-based telemedicine screening program for diabetic retinopathy.

Authors:  James E Benjamin; Justin Sun; Devin Cohen; Joseph Matz; Angela Barbera; Jeffrey Henderer; Lorrie Cheng; Julia Grachevskaya; Rajnikant Shah; Yi Zhang
Journal:  BMC Ophthalmol       Date:  2021-02-04       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.